The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
- Conditions
- Multiple Myeloma and Plasma Cell NeoplasmLeukemiaLymphoma
- Locations
- 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-08-18
- Last Posted Date
- 2012-05-03
- Target Recruit Count
- 40
- Registration Number
- NCT00003751
- Locations
- 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
🇺🇸Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
🇺🇸University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
- Conditions
- Leukemia
- Locations
- 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2004-08-04
- Last Posted Date
- 2012-11-14
- Target Recruit Count
- 45
- Registration Number
- NCT00003798
- Locations
- 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
- Conditions
- Brain and Central Nervous System Tumors
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Penclomedine in Treating Patients With Advanced Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Locations
- 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
- Conditions
- Pancreatic Cancer
- Interventions
- Biological: GVAX pancreatic cancer vaccine
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2013-07-22
- Target Recruit Count
- 60
- Registration Number
- NCT00084383
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-05-26
- Last Posted Date
- 2018-06-26
- Target Recruit Count
- 44
- Registration Number
- NCT00006358
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Simmons Cancer Center - Dallas, Dallas, Texas, United States
🇺🇸University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
UCN-01 in Treating Patients With Advanced Cancer
- Conditions
- LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
- Locations
- 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-05-20
- Last Posted Date
- 2012-05-03
- Target Recruit Count
- 54
- Registration Number
- NCT00004073
- Locations
- 🇺🇸
Emory University Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
🇺🇸University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States